It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: ChaoticOrder
a reply to: chr0naut
Prior to the outbreak, there were no known community cases in New Zealand.
The data shows New Zealand has had a couple of cases here and there almost every day since the pandemic began, so I have no idea what you are talking about. The recent wave in New Zealand is clearly getting so large because it's the Delta variant, like most places currently going through a wave. It's pretty funny though that you're still going on about the zero Covid dream in NZ...
New Zealand has had cases nearly every day, but they were cases in quarantine, as they were allowing travel from other places, but with immediate quarantine for travelers.
New Zealand had been successfully following protocols aimed at elimination of COVID-19 in the community. That is still the aim of the current lock-down, and it looks like it will be soon achievable, even with the current outbreak of Delta strain.
originally posted by: Zitterbewegung
a reply to: chr0naut
Where did you come up with 10% less deadly but 50% more contagious?
Assuming those percentages are correct please show the math.
It's late and I'm not in the mood to prove your math.
originally posted by: Zitterbewegung
a reply to: chr0naut
Derivation and algebra please instead of a Phil Spector wall of text. Thank you.
originally posted by: Zitterbewegung
a reply to: TheAMEDDDoc
I believe the right approach is to find something that prevents the spike protein binding with the ACE2 enzyme.
Even if the body is fighting off the spike protein via vaccines, the spike protein still can attack the brain, kidneys, lungs, testes, via the ACE2 enzyme.
Wait! OMG! WTF! look!
"Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2 "
"Conclusion: The ivermectin docking we identified may interfere with the attachment of the spike to the human cell membrane. Clinical trials now underway should determine whether ivermectin is an effective treatment for SARS-Cov2 infection. "
pubmed.ncbi.nlm.nih.gov...
N-Acetylcysteine, a Forgotten Immune-Modulating Agent
N-acetylcysteine (NAC), a precursor of the antioxidant glutathione, has been used to loosen thick mucus in the lungs and treat acetaminophen overdose for decades. However, NAC can also boost the immune system, suppress viral replication, and reduce inflammation. Despite these valuable features, NAC has been mostly overlooked throughout SARS-Cov and MERS-Cov epidemics, as well as the current COVID-19 pandemic.
Thiol-based drugs and thiol content determination
N-acetylcysteine (NAC) and MESNA were the pharmaceutical formulations, with NAC manufactured by American Reagent INC at 200mg/ml and MESNA by Baxter at 100mg/ml USP. Cysteamine (MilliporeSigma), amifostine (MilliporeSigma), WR-1065 (MilliporeSigma) and penicillamine (MP Biomedicals) were lyophilized powders that were solubilized as 500mM concentrated stocks in water. Cysteamine and WR-2065 were at pH 5. Amifostine was at pH 7 which was adjusted to pH 5. To ensure that amifostine does not auto-dephosphorylate to WR-1065, it was made fresh before the experiment each time. Bucillamine (MilliporeSigma) and tiopronin (Spectrum Chemicals) were lyophilized powders that were solubilized as 500mM concentrated stocks in equimolar NaOH to increase the solubility, and the pH was adjusted to pH 5. Carbocysteine (MilliporeSigma) and succimer (MilliporeSigma) were solubilized as 250mM concentrated stocks in 500mM NaOH to increase solubility with pH adjusted to pH 5. Free thiol content, and thus concentration of an active drug, was measured before every experiment using Ellman’s Reagent, 5,5’-dithio-bis-(2-nitrobenzoic acid) (DTNB) (Abcam), with the molar extinction coefficient of 14,150M−1cm−1 at 412nm24. Active drug concentration measured by DTNB was within 85 to 99% of nominal drug concentration. The stocks were stored at −20°C and discarded if the thiol content went below 85%. Drug concentrations reported in plate-binding and viral entry assays are based on active drug concentration in stock.
originally posted by: ChaoticOrder
a reply to: carewemust
That logic doesn't really work because many places are seeing more cases than ever before. What's getting lower is the death counts, which probably is partly due to what you said, but it's also due to the lower lethality of new strains.
originally posted by: ChaoticOrder
originally posted by: chr0naut
originally posted by: Zitterbewegung
In general mutated strains are more infectious but less deadly.
Could it be that the media is attributing the fact delta is less deadly to the vaccines and not reality?
A strain that is 10% less deadly for a set population, but 50% more contagious, will kill more people than a deadlier strain.
The Delta variant is killing a lot less people as the data shows, and seems to be almost 20-40% more contagious. So it must be a lot more than 10% less deadly.